Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

51.22 -4.29 (-7.73%)
Streaming Delayed Price Updated: 3:53 PM EDT, Apr 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,999,707
Open 54.35
Bid (Size) 51.20 (100)
Ask (Size) 51.23 (100)
Prev. Close 55.51
Today's Range 50.03 - 54.50
52wk Range 41.67 - 104.32
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus to Report First Quarter 2026 Financial Results on May 5
From Tempus AI, Inc.
Via Business Wire

Performance

YTD
-17.9%
-17.9%
1 Month
+4.2%
+4.2%
3 Month
-21.6%
-21.6%
6 Month
-39.9%
-39.9%
1 Year
+18.5%
+18.5%

More News

Read More
News headline image
Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease
From Tempus AI, Inc.
Via Business Wire
News headline image
2 AI Healthcare Stocks to Buy Right Now ↗
Via The Motley Fool
Topics Artificial Intelligence
Tempus AI Inc (NASDAQ:TEM) Reports Strong Q4 Revenue Beat and First Positive Adjusted EBITDA ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
Want $1 Million in Retirement? Invest $10,000 in These 2 AI Stocks and Hold for 10 Years. ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine
From Tempus AI, Inc.
Via Business Wire
MarketBeat Week in Review – 02/23 - 02/27 ↗
Via MarketBeat
News headline image
After a Near 50% Drop, Tempus AI Could Be Ripe for a Rebound ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus AI Sold Off After a Beat—But the Rebound Case Is Building ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
Tempus Reports Fourth Quarter and Full Year 2025 Results
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24
From Tempus AI, Inc.
Via Business Wire
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Ambry’s Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes
From Ambry Genetics
Via Business Wire
News headline image
Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield
From Ambry Genetics
Via Business Wire
News headline image
Here Are Congresswoman Nancy Pelosi's Initial Stock Moves in 2026: They Include Nvidia, Alphabet, and Amazon Stocks, and Others ↗
Via The Motley Fool
Topics Bonds
News headline image
Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers
From Tempus AI, Inc.
Via Business Wire
News headline image
Pelosi’s Bullish 2026 Buy List: AI, Power & Dividends ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
Tempus Announces the Launch of Paige Predict
From Tempus AI, Inc.
Via Business Wire

Frequently Asked Questions

Is Tempus AI, Inc. - Class A Common Stock publicly traded?
Yes, Tempus AI, Inc. - Class A Common Stock is publicly traded.
What exchange does Tempus AI, Inc. - Class A Common Stock trade on?
Tempus AI, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tempus AI, Inc. - Class A Common Stock?
The ticker symbol for Tempus AI, Inc. - Class A Common Stock is TEM on the Nasdaq Stock Market
What is the current price of Tempus AI, Inc. - Class A Common Stock?
The current price of Tempus AI, Inc. - Class A Common Stock is 51.22
When was Tempus AI, Inc. - Class A Common Stock last traded?
The last trade of Tempus AI, Inc. - Class A Common Stock was at 04/23/26 03:53 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.